BIO - Day 2
On Wednesday, the day begins with keynote Dr Robert Califf, current and former FDA Commissioner.
J&J files Carvykti for earlier use in multiple myeloma
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
ASCO 2023 – Arun Krishna
With a 51% reduction in deaths, AstraZeneca’s ADAURA trial was one of the breakout stories of this year’s ASCO.
GSK claims first EU approval for an RSV vaccine
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
mRNA Cancer Vaccine Summit 2023
The mRNA Cancer Vaccine Summit 2023 comes to Boston as the community is on the cusp of something truly exciting.
Welcome to the 5th TIL Therapies Summit!
The first commercial TIL therapy is brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, along with the 5th TIL Therapies Summit whic
2nd Process Development for Cell Therapies
View the program here
5th Exosome Based Therapeutic Development Summit
The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translatio
8th CAR-TCR Summit
The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug develope